Medzy Drugs & Surgicals Llp - Company Profile

It is a service limited liability partnership based in Tirur, Kerala, India, established in 2020.
2020 Tirur, Kerala, India Active
Last Updated:
Access Report
About Medzy Drugs & Surgicals Llp

Medzy Drugs & Surgicals Llp, a active limited liability partnership, was established on 18 December 2020 in Tirur, Kerala, India. Engaging in other services within the service sector, it holds LLPIN: AAV-1601. Registered under ROC Roc Ernakulam. It has total obligation of contribution of ₹2.50 M.

Its leadership includes Fasil (Designated Partner), Mohamed Fayas (Designated Partner). Past directors included Cheruthottathil Mohamed Nabeel, Safoora Kundil. Its latest date of accounts and solvency statement 31 March 2025. It is based at 15/63 A, 63 B, Union Square, Panbazar, Opposite City Hospital Road, Tirur, Kerala, 676101.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAV-1601

  • Incorporation Date

    18 December 2020

  • Total Obligation of Contribution

    ₹2.50 M

  • ROC Code

    Roc Ernakulam

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 2.50 M
  • Company Age 5 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Medzy Drugs & Surgicals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medzy Drugs & Surgicals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medzy Drugs & Surgicals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Fasil Designated Partner 08 Feb 2025 Current
Mohamed Fayas Designated Partner 23 Jun 2025 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 23 Jun 2025 Past
Pramod Abcsdd Designated Partner 08 Feb 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medzy Drugs & Surgicals Llp.

Enhance accessibility to Medzy Drugs & Surgicals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Medzy Drugs & Surgicals Llp revenue growth over time
Medzy Drugs & Surgicals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medzy Drugs & Surgicals Llp?

Unlock access to Medzy Drugs & Surgicals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Medzy Drugs & Surgicals Llp?

Unlock and access historical data on people associated with Medzy Drugs & Surgicals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medzy Drugs & Surgicals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medzy Drugs & Surgicals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medzy Drugs & Surgicals Llp
Recent Activity within the Organization
  • Director Appointment

    Progress on Mohamed Fayas was appointed as a Designated Partner was appointed as a Designated Partner on 23 Jun 2025 & has been associated with this company since 8 months 10 days . was documented.

  • Annual General Meeting

    Medzy Drugs & Surgicals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    Medzy Drugs & Surgicals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was recorded as a recent event.

  • Director Appointment

    Fasil was appointed as a Designated Partner was appointed as a Designated Partner on 08 Feb 2025 & has been associated with this company since 1 year 23 days . was recorded as a recent event.

  • LLP Incorporation

    Medzy Drugs & Surgicals Llp was registered on 18 Dec 2020 with Roc Ernakulam & aged 5 years 2 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Medzy Drugs & Surgicals Llp?

The LLPIN of Medzy Drugs & Surgicals Llp is AAV-1601.

Where is Medzy Drugs & Surgicals Llp headquartered?

Medzy Drugs & Surgicals Llp is headquartered at 15/63 A, 63 B, Union Square, Panbazar, Opposite City Hospital Road, Tirur, Kerala, 676101.

When was Medzy Drugs & Surgicals Llp incorporated?

Medzy Drugs & Surgicals Llp was incorporated on 18 December 2020.

Who are the current directors of Medzy Drugs & Surgicals Llp?

The current directors of Medzy Drugs & Surgicals Llp are

What is the primary industry of Medzy Drugs & Surgicals Llp?

The primary industry of Medzy Drugs & Surgicals Llp is Service.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available